Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Assessing Diaphragm Activity and Breathing Mechanics During NAVA Ventilation

Official title: Evaluation of the Relationship Between Electrical Activity of the Diaphragm and Respiratory Mechanics During Neurally Adjusted Ventilatory Assist in Lung Transplant Patients and in Patients Affected by Acute Respiratory Failure.

Run by University of Padova · NCT05689476 · Data updated 2026-11-12

This study is testing if a special type of breathing support called NAVA can help lung transplant patients breathe better and protect their lungs while they recover in the ICU.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Padova
Academic / other
Locations1 site (Padova, Italy)
StatusRecruiting
StartedDecember 27, 2022
Main results expectedDecember 27, 2025
Study endsDecember 27, 2025
Registry record updatedJuly 8, 2025
Trial IDNCT05689476 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who are admitted to the ICU for monitoring after lung transplantation and exhibit spontaneous breathing activity.

Probably not a fit

Patients with severe hemodynamic instability or contraindications to nasogastric tube insertion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Neurally Adjusted Ventilatory Assist (NAVA) in patients who have undergone lung transplantation. It focuses on the relationship between the electrical activity of the diaphragm and various respiratory parameters, such as tidal volume and driving pressure, during different levels of ventilatory support. The goal is to understand how NAVA can reduce ventilator-induced lung injury and diaphragm dysfunction in the early postoperative period. Participants will be monitored in the ICU to assess their spontaneous breathing activity and response to NAVA.

Why it matters

Potential benefit: If successful, this approach could significantly improve respiratory outcomes and reduce complications for lung transplant patients.

How similar studies have gone: While the use of NAVA is established, this specific evaluation of its effects post-lung transplantation is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 y.o.
* Admission to ICU for post-operative monitoring after LTx or acute respiratory failure needing invasive mechanical ventilation
* Presence of spontaneous breathing activity
* Sedation titrated to a target RASS between 0 and -2
* Written informed consent obtained

Exclusion Criteria:

* Contraindication to nasogastric tube insertion (gastroesophageal surgery in the previous 3 months, gastroesophageal bleeding in the previous 30 days, history of esophageal varices, facial trauma)
* Increased risk of bleeding with nasogastric tube insertion, due to severe coagulation disorders and severe thrombocytopenia ( i.e., INR \> 2 and platelets count \< 70.000/mm3)
* Severe hemodynamic instability (noradenaline \> 0.3 μg/kg/min and/or use of vasopressin)
* Postoperative extracorporeal respiratory support (ECMO)
* Pre-operative reconditioning of the transplanted lungs by means of ex-vivo lung perfusion (EVLP)
* Lung retransplantation
* Failure to obtain a stable EAdi signal

Where it's running

  • Institute of Anaesthesia and Intensive Care, Padua University hospital
    Padova, Italy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.